ATP release and purinergic signaling in NLRP3 inflammasome activation
- PMID: 23316199
- PMCID: PMC3539150
- DOI: 10.3389/fimmu.2012.00414
ATP release and purinergic signaling in NLRP3 inflammasome activation
Abstract
The NLRP3 inflammasome is a protein complex involved in IL-1β and IL-18 processing that senses pathogen- and danger-associated molecular patterns (PAMPs and DAMPs). One step- or two step-models have been proposed to explain the tight regulation of IL-1β production during inflammation. Moreover, cellular stimulation triggers adenosine triphosphate (ATP) release and subsequent activation of purinergic receptors at the cell surface. Importantly some studies have reported roles for extracellular ATP, in NLRP3 inflammasome activation in response to PAMPs and DAMPs. In this mini review, we will discuss the link between active ATP release, purinergic signaling and NLRP3 inflammasome activation. We will focus on the role of autocrine or paracrine ATP export in particle-induced NLRP3 inflammasome activation and discuss how particle activators are competent to induce maturation and secretion of IL-1β through a process that involves, as a first event, extracellular release of endogenous ATP through hemichannel opening, and as a second event, signaling through purinergic receptors that trigger NLRP3 inflammasome activation. Finally, we will review the evidence for ATP as a key pro-inflammatory mediator released by dying cells. In particular we will discuss how cancer cells dying via autophagy trigger ATP-dependent NLRP3 inflammasome activation in the macrophages engulfing them, eliciting an immunogenic response against tumors.
Keywords: ATP; NLRP3; P2R; autophagic cell death; danger signal; inflammasome; purinergic signaling.
Figures


Similar articles
-
Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.Clin Exp Pharmacol Physiol. 2014 Apr;41(4):279-86. doi: 10.1111/1440-1681.12214. Clin Exp Pharmacol Physiol. 2014. PMID: 24472059
-
The anti-tumorigenic mushroom Agaricus blazei Murill enhances IL-1β production and activates the NLRP3 inflammasome in human macrophages.PLoS One. 2012;7(7):e41383. doi: 10.1371/journal.pone.0041383. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844468 Free PMC article.
-
TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.J Immunol. 2013 Jan 1;190(1):334-9. doi: 10.4049/jimmunol.1202737. Epub 2012 Dec 7. J Immunol. 2013. PMID: 23225887 Free PMC article.
-
Interplay Between NLRP3 Inflammasome and Autophagy.Front Immunol. 2020 Oct 9;11:591803. doi: 10.3389/fimmu.2020.591803. eCollection 2020. Front Immunol. 2020. PMID: 33163006 Free PMC article. Review.
-
Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.Trends Immunol. 2018 May;39(5):393-406. doi: 10.1016/j.it.2018.01.009. Epub 2018 Feb 13. Trends Immunol. 2018. PMID: 29452983 Review.
Cited by
-
Understanding the Role of Inflammasomes in Rheumatoid Arthritis.Inflammation. 2020 Dec;43(6):2033-2047. doi: 10.1007/s10753-020-01301-1. Inflammation. 2020. PMID: 32712858 Review.
-
Interferon-γ in Salmonella pathogenesis: New tricks for an old dog.Cytokine. 2017 Oct;98:27-32. doi: 10.1016/j.cyto.2016.10.009. Epub 2016 Oct 20. Cytokine. 2017. PMID: 27773552 Free PMC article. Review.
-
Purinergic Receptor Antagonists: A Complementary Treatment for Hypertension.Pharmaceuticals (Basel). 2024 Aug 13;17(8):1060. doi: 10.3390/ph17081060. Pharmaceuticals (Basel). 2024. PMID: 39204165 Free PMC article. Review.
-
The role of neutrophils in thrombosis.Thromb Res. 2018 Oct;170:87-96. doi: 10.1016/j.thromres.2018.08.005. Epub 2018 Aug 9. Thromb Res. 2018. PMID: 30138777 Free PMC article. Review.
-
The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury.Front Cell Dev Biol. 2020 Mar 12;8:140. doi: 10.3389/fcell.2020.00140. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32226786 Free PMC article. Review.
References
-
- Abbracchio M. P., Burnstock G., Boeynaems J. M., Barnard E. A., Boyer J. L., Kennedy C., et al. (2006). International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58 281–341 - PMC - PubMed
-
- Aganna E., Martinon F., Hawkins P. N., Ross J. B., Swan D. C., Booth D. R., et al. (2002). Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46 2445–2452 - PubMed
-
- Agostini L., Martinon F., Burns K., Mcdermott M. F., Hawkins P. N., Tschopp J. (2004). NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 20 319–325 - PubMed
-
- Ataman-Onal Y., Munier S., Ganee A., Terrat C., Durand P. Y., Battail N., et al. (2006). Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J. Control. Release 112 175–185 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous